Crescita Therapeutics Inc.
CRRTF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | -$0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -13.5% | 76.2% | -48.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 52.9% | 61.4% | 49.4% | 43.4% |
| EBITDA | $0 | $0 | -$0 | $0 |
| % Margin | 21.3% | 18.7% | -16% | 3% |
| Net Income | $0 | $0 | -$0 | -$0 |
| % Margin | 14% | 12.8% | -26.4% | -2.3% |
| EPS Diluted | 0.04 | 0.04 | -0.05 | -0.008 |
| % Growth | 0% | 180% | -495.2% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | $0 |